Literature DB >> 16688788

Towards a lung adenocarcinoma proteome map: studies with SP-C/c-raf transgenic mice.

Heike Rütters1, Petra Zürbig, Roman Halter, Jürgen Borlak.   

Abstract

We report mapping of proteins of adenocarcinomas of the lung as a result of overexpression of the oncogenically activated N-terminal deletion mutant c-raf-1 BxB through usage of the human SP-C promotor. Proteins from non-transgenic controls and tumors were extracted with a lysis buffer containing 5 mol/L urea, 2 mol/L thiourea, 40 mmol/L Tris, 4% CHAPS, 100 mmol/L DTT, 0.5% BioLyte 3-10, separated by 2-DE and studied by image analysis. On average, 300-600 protein spots per gel were excised and analyzed by MALDI-TOF and -TOF/TOF MS. More than 1000 of the CBB-stained proteins were identified and traced back to 100 different gene products, including many of their isoforms. We observed significant changes in the expression of proteins involved in cellular defense or glycolysis, and this included glutathione S-transferase, peroxiredoxin 6, and alpha-enolase, among others. Proteins associated with lung tumor growth and/or metastasis, i.e., lung carbonyl reductase, differed in expression, as did tumor-associated expression of cell adhesion and membrane-bound proteins such as vinculin. This map provides valuable insight into expression of pulmonary proteins associated with lung adenocarcinomas, some of which may be of utility as diagnostic markers in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16688788     DOI: 10.1002/pmic.200500188

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  8 in total

Review 1.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

Review 2.  Raf kinases: function, regulation and role in human cancer.

Authors:  Deborah T Leicht; Vitaly Balan; Alexander Kaplun; Vinita Singh-Gupta; Ludmila Kaplun; Melissa Dobson; Guri Tzivion
Journal:  Biochim Biophys Acta       Date:  2007-05-22

3.  Combined micro-PET/micro-CT imaging of lung tumours in SPC-raf and SPC-myc transgenic mice.

Authors:  Thomas Rodt; Matthias Luepke; Claudia Boehm; Katja Hueper; Roman Halter; Silke Glage; Ludwig Hoy; Frank Wacker; Juergen Borlak; Christian von Falck
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

4.  Lung tumour growth kinetics in SPC-c-Raf-1-BB transgenic mice assessed by longitudinal in-vivo micro-CT quantification.

Authors:  Thomas Rodt; Christian von Falck; Sabine Dettmer; Katja Hueper; Roman Halter; Ludwig Hoy; Matthias Luepke; Juergen Borlak; Frank Wacker
Journal:  J Exp Clin Cancer Res       Date:  2012-02-20

Review 5.  Preclinical Murine Models for Lung Cancer: Clinical Trial Applications.

Authors:  Amelia Kellar; Cay Egan; Don Morris
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

6.  Molecular characterization of lung dysplasia induced by c-Raf-1.

Authors:  Astrid Rohrbeck; Volker Steffen Müller; Jürgen Borlak
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

7.  Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic.

Authors:  R Clark Lantz; Brandon J Lynch; Scott Boitano; Gerald S Poplin; Sally Littau; George Tsaprailis; Jefferey L Burgess
Journal:  Environ Health Perspect       Date:  2007-01-08       Impact factor: 9.031

8.  A cross-platform comparison of affymetrix and Agilent microarrays reveals discordant miRNA expression in lung tumors of c-Raf transgenic mice.

Authors:  Valerio Del Vescovo; Tatiana Meier; Alberto Inga; Michela Alessandra Denti; Juergen Borlak
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.